妇科癌症中的NRF2/KEAP1信号通路抑制剂 - Suppr

Suppr

超能文献

NRF2/KEAP1 signaling inhibitors in gynecologic cancers.

作者信息

Fantone Sonia, Marzioni Daniela, Tossetta Giovanni

机构信息

Scientific Direction, IRCCS INRCA, Ancona, Italy.

IRCCS INRCA, Ancona, Italy.

出版信息

Expert Rev Anticancer Ther. 2024 Dec;24(12):1191-1194. doi: 10.1080/14737140.2024.2438951. Epub 2024 Dec 7.

DOI:10.1080/14737140.2024.2438951

PMID:39636348

Abstract

摘要

相似文献

NRF2/KEAP1 signaling inhibitors in gynecologic cancers.妇科癌症中的NRF2/KEAP1信号通路抑制剂

Expert Rev Anticancer Ther. 2024 Dec;24(12):1191-1194. doi: 10.1080/14737140.2024.2438951. Epub 2024 Dec 7.

Targeting the NRF2/KEAP1 pathway in cervical and endometrial cancers.靶向宫颈癌和子宫内膜癌中的NRF2/KEAP1信号通路。

Eur J Pharmacol. 2023 Feb 15;941:175503. doi: 10.1016/j.ejphar.2023.175503. Epub 2023 Jan 12.

mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: a critical review.mTOR 抑制剂及其在宫颈癌、子宫内膜癌和卵巢癌中的临床应用：批判性评价。

Gynecol Oncol. 2014 May;133(2):375-81. doi: 10.1016/j.ygyno.2014.02.017. Epub 2014 Feb 18.

Prevalence and Landscape of Pathogenic or Likely Pathogenic Germline Variants and Their Association With Somatic Phenotype in Unselected Chinese Patients With Gynecologic Cancers.未选择的中国妇科癌症患者种种系致病性或可能致病性变体的流行情况及其与体细胞表型的相关性。

JAMA Netw Open. 2023 Jul 3;6(7):e2326437. doi: 10.1001/jamanetworkopen.2023.26437.

KEAP1/NRF2 signaling pathway mutations in cervical cancer.宫颈癌中 KEAP1/NRF2 信号通路的突变。

Eur Rev Med Pharmacol Sci. 2018 Jul;22(14):4458-4466. doi: 10.26355/eurrev_201807_15497.

Clinical statistics of gynecologic cancers in Japan.日本妇科癌症的临床统计数据。

J Gynecol Oncol. 2017 Mar;28(2):e32. doi: 10.3802/jgo.2017.28.e32. Epub 2017 Feb 10.

Expression Patterns of Nrf2 and Keap1 in Ovarian Cancer Cells and their Prognostic Role in Disease Recurrence and Patient Survival.Nrf2和Keap1在卵巢癌细胞中的表达模式及其在疾病复发和患者生存中的预后作用。

Int J Gynecol Cancer. 2017 Mar;27(3):412-419. doi: 10.1097/IGC.0000000000000908.

Keap1-targeting microRNA-941 protects endometrial cells from oxygen and glucose deprivation-re-oxygenation via activation of Nrf2 signaling.Keap1 靶向 microRNA-941 通过激活 Nrf2 信号通路保护子宫内膜细胞免于缺氧/葡萄糖剥夺再复氧损伤。

Cell Commun Signal. 2020 Feb 26;18(1):32. doi: 10.1186/s12964-020-0526-0.

Novel Therapies in Gynecologic Cancer.妇科癌症的新型治疗方法。

Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-17. doi: 10.1200/EDBK_351294.

Renin-Angiotensin-Aldosterone System Inhibitors and Development of Gynecologic Cancers: A 23 Million Individual Population-Based Study.肾素-血管紧张素-醛固酮系统抑制剂与妇科癌症的发展：一项 2300 万人的基于人群的研究。

Int J Mol Sci. 2023 Feb 14;24(4):3814. doi: 10.3390/ijms24043814.

引用本文的文献

Ferroptosis and Nrf2 Signaling in Head and Neck Cancer: Resistance Mechanisms and Therapeutic Prospects.头颈癌中的铁死亡与Nrf2信号传导：耐药机制与治疗前景

Antioxidants (Basel). 2025 Aug 13;14(8):993. doi: 10.3390/antiox14080993.

Molecular mechanisms and therapeutic strategies of GPX4 regulation in acute kidney injury.急性肾损伤中GPX4调控的分子机制与治疗策略

Pharmacol Rep. 2025 Aug 28. doi: 10.1007/s43440-025-00777-8.

N-butylphthalide (NBP) and ligustrazine (TMP) triazole hybrids target the KEAP1-NRF2 pathway to inhibit ferroptosis and exert brain neuroprotectivity.正丁基苯酞（NBP）和川芎嗪（TMP）三唑杂化物靶向KEAP1-NRF2通路以抑制铁死亡并发挥脑神经保护作用。

Redox Biol. 2025 Aug 20;86:103835. doi: 10.1016/j.redox.2025.103835.

Antioxidants and Reactive Oxygen Species: Shaping Human Health and Disease Outcomes.抗氧化剂与活性氧：塑造人类健康与疾病结局

Int J Mol Sci. 2025 Aug 4;26(15):7520. doi: 10.3390/ijms26157520.

Effect of natural compounds on NRF2/KEAP1 signaling in periodontitis: a potential use to prevent age-related disorders.天然化合物对牙周炎中NRF2/KEAP1信号通路的影响：预防与年龄相关疾病的潜在用途。

Mol Biol Rep. 2025 Jul 30;52(1):771. doi: 10.1007/s11033-025-10878-5.

Bardoxolone Methyl: A Comprehensive Review of Its Role as a Nrf2 Activator in Anticancer Therapeutic Applications.甲基巴多索隆：对其作为Nrf2激活剂在抗癌治疗应用中的作用的全面综述。

Pharmaceuticals (Basel). 2025 Jun 27;18(7):966. doi: 10.3390/ph18070966.

Inhibition of gastric adenocarcinoma proliferation by WSGC@MS: Role of KEAP1/NRF2 signaling pathway and autophagy regulation.WSGC@MS对胃腺癌增殖的抑制作用：KEAP1/NRF2信号通路及自噬调节的作用

Mater Today Bio. 2025 Jun 16;33:101995. doi: 10.1016/j.mtbio.2025.101995. eCollection 2025 Aug.

and in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review).以及在精准肿瘤学中：与同源重组缺陷（HRD）相关的乳腺癌和卵巢癌的临床意义（综述）

Int J Oncol. 2025 Aug;67(2). doi: 10.3892/ijo.2025.5771. Epub 2025 Jul 4.

Phytochemical nanozymes reprogram redox for balanced antimicrobial and regenerative therapy in acute and chronic diabetic wounds.植物化学纳米酶重新编程氧化还原，用于急性和慢性糖尿病伤口的抗菌和再生平衡治疗。

Redox Biol. 2025 Jun 6;85:103718. doi: 10.1016/j.redox.2025.103718.

TSPAN15 sustains ITGB1 stability to block gemcitabine-induced ferroptosis in pancreatic ductal adenocarcinoma through the FAK/AKT/Mtor-gpx4 cascade.TSPAN15通过FAK/AKT/Mtor-gpx4级联维持ITGB1稳定性，以阻断吉西他滨诱导的胰腺导管腺癌铁死亡。

Redox Biol. 2025 Jun 8;85:103721. doi: 10.1016/j.redox.2025.103721.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验